Navigation Links
Vermillion Announces First Quarter 2008 Financial Results and Business Progress
Date:5/15/2008

nd Subsidiaries

Condensed Consolidated Statements of Operations

(In Thousands, Except Per Share Amounts)

(Unaudited)

Three Months Ended

March 31,

2008 2007

Revenue:

Products $5 $-

Services 48 21

Total revenue 53 21

Cost of revenue:

Products 2 -

Services 20 15

Total cost of revenue 22 15

Gross profit 31 6

Operating expenses:

Research and development 1,875 1,990

Sales and marketing 893 477

General and administrative 1,827 3,197

Total operating expenses 4,595 5,664

Loss from operations (4,564) (5,658)

Interest and other income (expense), net (332) (383)

Loss before income taxes (4,896) (6,041)

Income tax benefit (expense) 50 (6)

Net loss $(4,846) $(6,047)

Loss per share - basic and diluted (1) $(0.76) $(1.54)

Shares used to compute basic and diluted loss

per common share (1) 6,380,188 3,923,291

(1) Adjuste
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
10. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
11. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Pittcon is pleased to announce that ... Matsuda, Horiba Scientific, have organized a session on nanotechnology ... JASIS , Asia’s largest analytical and scientific instruments show, ... Japan. , The four speakers in this U.S. ... Molecules to Single Cells” will present their use of ...
(Date:8/29/2014)... VANCOUVER , Aug. 29, 2014 /PRNewswire/ - ... (OTCQX: ICOTF), today reported financial results for the ... specified otherwise, are expressed in Canadian dollars and ... Second Quarter 2014 Highlights , ... visual acuity (VA) primary endpoint for subjects enrolled ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Local veterinarian, ... Veterinary Hospital are seeking candidates to participate in an ... osteoarthritis. The ultimate goal of this study is ... cells into one or two arthritically affected joints can ... , Candidates for the current investigational study must ...
(Date:8/29/2014)... 2014 Three Lawrence Livermore researchers ... Hydrogen Production R&D Award for their research ... using sunlight. , Shared with collaborators from the ... of Nevada, Las Vegas (UNLV), the award recognizes ... photoelectrochemical solar-hydrogen production and corrosion processes. , These ...
Breaking Biology Technology:Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2Livermore Team Awarded for Hydrogen Production Research 2
... Medical Design Excellence Awards is the Premier ... April 8, 2008 MEDRAD, Inc.,and Battelle, ... organization, today announced the winning of a ... XDS(TM) Extravasation Detector, a,technology that enhances the ...
... Insurance Companies Expected To Match Medicare Policy, ... The Centers for,Medicare and Medicaid Services ... sleep apnea (OSA). Previous policy had mandated ... The,new policy allows continuous positive airway pressure ...
... MILLBROOK, N.Y., April 8, 2008 Donald C. ... of Daniel,Petrylak, MD as Chairman of the company,s ... of Medicine at Columbia,University Medical Center where he ... He is the co-author of numerous peer reviewed,scientific ...
Cached Biology Technology:MEDRAD, Battelle Win Medical Design Excellence Award for MEDRAD XDS(TM) Extravasation Detector 2Medicare Approves in Home Sleep Apnea Testing 2
(Date:8/28/2014)... app called TX Invasives is now available from the ... Texas at Austin for identifying harmful non-native plant, insect ... in the United States cause about $137 billion in ... crops, clog waterways, kill native plants and more. , ... for reporting where invasive species occur, we,re more likely ...
(Date:8/28/2014)... study reports that an expansion of marine protected areas ... ecological functions. According to investigators from the Wildlife ... fish have focused on saving the largest numbers of ... provide key and difficult-to-replace ecological functions. , ... by fish species that also are food for millions ...
(Date:8/28/2014)... FASEB MARC (Maximizing Access to Research Careers) Program ... Society of Human Genetics from October 18 22, ... meant to promote the entry of students, post doctorates ... the basic science community and to encourage the participation ... Genetics. This year MARC conferred 16 awards totaling ...
Breaking Biology News(10 mins):Mobile app makes ID of harmful plants, insects in Texas a snap 2Study finds marine protected areas inadequate for protecting fish and ocean ecology 2
... Ohio Recent research that links specific pieces of ... lead the way to the prevention of viroids, pathogens ... plants. The findings and the research approach ... applications in the study of how certain viruses spread ...
... us have missed a dose of antibiotic or forgotten to ... as they are for people with HIV/AIDS a ... for the entire population. Now, a breath monitoring device ... Inc. could help prevent the emergence of drug-resistant strains of ...
... definitive critical review, scientists at Childrens Hospital & ... biological or behavioral evidence linking vitamin D deficiency ... staff scientist and Bruce N. Ames, Ph.D., senior ... conclude that there is ample biological evidence to ...
Cached Biology News:Analysis of RNA role in spreading disease advances study of damaging plant infections 2Analysis of RNA role in spreading disease advances study of damaging plant infections 3Analysis of RNA role in spreading disease advances study of damaging plant infections 4Scientists test device to track medication adherence in patients with HIV/AIDS 2Scientists test device to track medication adherence in patients with HIV/AIDS 3Vitamin D in brain function 2Vitamin D in brain function 3
... member of the family of human cullin genes (CUL-1, ... S. cerevisiae cdc53 gene. Cullin-3 is proposed to be ... tight complex with cyclin E and targets it for ... E is an activator of cdk2, which leads the ...
Yellow oily liquid. Contains 85% Drakeol 5NF, 15% Arlacel A (mannide monooleate emulsifier). Heat sterilized. Contains zero colony forming units/ml. ...
... nm; includes interface cable to S2000; can be ... or desktop boxes The LS-450 Blue ... produces either pulsed or continuous output at 470 ... measurements. The source is designed for use with ...
... for microRNA expression profiling ,miRCURY ... Locked Nucleic Acid (LNA) technology to provide ... short microRNA (miRNA) targets. miRCURY LNA Arrays ... RNA (no need for microRNA enrichment) labeled ...
Biology Products: